Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

27 mars 2026 11h12 HE | Source: Research and Markets

Competitive Insights and Expert Consultation on the Growing Oncology Nutrition Market, 2026-2030: A $3.27 Billion Opportunity

Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Oncology Nutrition Market Report 2026" has been added to ResearchAndMarkets.com's offering. The oncology nutrition market has shown robust...
27 mars 2026 10h13 HE | Source: Research and Markets

Radiation Oncology Market Outlook Report 2026-2030: Industry Anticipated to Reach $13.5 Billion by 2030

Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Radiation Oncology Market Report 2026" has been added to ResearchAndMarkets.com's offering. The radiation oncology market is poised for...
24 févr. 2026 09h00 HE | Source: Alpha Tau Medical Ltd.

Alpha Tau Medical Receives Japanese Marketing Approval for Alpha DaRT® in Unresectable Locally Advanced or Locally Recurrent Head and Neck Cancer

- Approval establishes first clinical authorization outside Israel and initiates post-market surveillance program - - First-in-kind technology delivers intra-tumoral alpha-emitting radiotherapeutics,...
23 janv. 2026 07h02 HE | Source: Research and Markets

PD-1 Resistant Head and Neck Cancer Market Research 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "PD-1 Resistant Head and Neck Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
21 janv. 2026 11h12 HE | Source: Research and Markets

Photoimmunotherapy Market to Surge with 10.64% CAGR, Reaching USD 3.65 Billion by 2031

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Photoimmunotherapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's...
25 nov. 2025 10h01 HE | Source: Research and Markets

PD-1 Resistant Head and Neck Cancer Market Research Report 2025-2030: Cracking the Code of Immunotherapy Resistance - How Sox9 and Anxa1 Shape the Tumor-Immune Standoff

Dublin, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The "PD-1 Resistant Head and Neck Cancer - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...
19 nov. 2025 10h06 HE | Source: Research and Markets

Head and Neck Squamous Cell Carcinoma Market Research Report 2025-2035: Sanofi, Sun Pharma, and Eli Lilly Lead Through the Development of New Drugs, Clinical Trials, Combination Treatment Strategies

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Head and Neck Squamous Cell Carcinoma Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast,...
22 oct. 2025 07h00 HE | Source: Galera Therapeutics

Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million

Galera Therapeutics Announces Acquisition of Avasopasem and the Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
24 juil. 2025 04h51 HE | Source: Research and Markets

Radiation Oncology Strategic Research Report 2025 | Market to Reach $10.2 Billion by 2030 - Surge in Awareness Campaigns on Early Cancer Detection Supports Growth

Dublin, July 24, 2025 (GLOBE NEWSWIRE) -- The "Radiation Oncology - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Radiation...
02 juin 2025 08h00 HE | Source: PDS Biotechnology Corporation

PDS Biotech Unveils Updated Positive Data From VERSATILE-002 Trial and Additional Trials Evaluating Versamune® HPV to Treat Head and Neck Cancers at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

PDS Biotech announced the publication of three Versamune® HPV abstracts that were presented during the Head and Neck Cancer Poster Session at ASCO 2025.

Page suivante